Cash and cash equivalents (USD, thousands)

Accounts receivable, net (USD, thousands)

Prepaid expenses and other current assets (USD, thousands)

Total current assets (USD, thousands)

Property, plant and equipment, net (USD, thousands)

Operating lease right-of-use assets, net (USD, thousands)

Goodwill (USD, thousands)

Intangible assets, net (USD, thousands)

Deferred income tax asset (USD, thousands)

Other assets (USD, thousands)

Total assets (USD, thousands)

Accounts payable (USD, thousands)

Accrued expenses and other current liabilities (USD, thousands)

Current portion of debt (USD, thousands)

Current portion of lease obligations (USD, thousands)

Total current liabilities (USD, thousands)

Debt, net of current portion (USD, thousands)

Non-current lease obligations (USD, thousands)

Deferred income tax liability (USD, thousands)

Other liabilities (USD, thousands)

Total liabilities (USD, thousands)

Common Stock, $0.0001 par value, 121,476,215 shares issued and outstanding at December 31, 2024 (USD, thousands)

Additional paid-in capital (USD, thousands)

Accumulated earnings (deficit) (USD, thousands)

Accumulated other comprehensive loss (USD, thousands)

Total equity (USD, thousands)

Total liabilities and equity (USD, thousands)

29e2255127ca4990ee54e7502650b9bbcc1a326d571b9510549dbe8fa14fae1a

Service Revenue (USD, thousands)

Cost of Revenue (USD, thousands)

Gross Profit (USD, thousands)

Selling, General and Administrative Expenses (USD, thousands)

Transaction Costs (USD, thousands)

Income (Loss) from Operations (USD, thousands)

Interest Expense, Net (USD, thousands)

Loss (Gain) on Extinguishment of Debt (USD, thousands)

Other Income, Net (USD, thousands)

Income (Loss) Before Provision for Income Taxes (USD, thousands)

Provision (Benefit) for Income Taxes (USD, thousands)

Net Income (Loss) (USD, thousands)

Foreign Currency Translation Adjustments (USD, thousands)

Total Other Comprehensive Income (Loss) (USD, thousands)

Total Comprehensive Income (Loss) (USD, thousands)

Basic Loss per Common Share and Series A Preferred Stock (USD)

Diluted Loss per Common Share and Series A Preferred Stock (USD)

Basic Income (Loss) per Common Share (USD)

Diluted Income (Loss) per Common Share (USD)

Weighted Average Common Shares Outstanding, Basic and Diluted

Weighted Average Shares of Series A Preferred Stock Outstanding, Basic and Diluted

Weighted Average Common Shares Outstanding, Basic

Weighted Average Common Shares Outstanding, Diluted

15df40fb700a927662af0c40d8dce29d9eee7e9f5051eac94f9b5b8f519f1c34

United States

Canada

- Corporate & Eliminations

Total Revenue

6ec7242708ff75f21241f470568f969578219640cf778465e6f8498bfe09965c

Net income (loss) [USD, thousands]

Provision for credit losses [USD, thousands]

Depreciation and amortization [USD, thousands]

Noncash lease expense [USD, thousands]

Share-based compensation expense [USD, thousands]

Amortization of deferred financing costs [USD, thousands]

Loss on extinguishment of debt [USD, thousands]

Fair value adjustments on interest rate derivatives [USD, thousands]

Deferred income taxes [USD, thousands]

Other [USD, thousands]

Changes in accounts receivable [USD, thousands]

Changes in prepaid expenses and other current assets [USD, thousands]

Changes in accounts payable [USD, thousands]

Changes in accrued expenses and other current liabilities [USD, thousands]

Changes in operating lease obligations [USD, thousands]

Changes in other assets and liabilities [USD, thousands]

Net cash provided by operating activities [USD, thousands]

Purchases of property, plant and equipment [USD, thousands]

Proceeds from sale of property, plant and equipment [USD, thousands]

Acquisition of ASP Acuren, net of cash acquired [USD, thousands]

Acquisition of businesses, net of cash acquired [USD, thousands]

Net cash used in investing activities [USD, thousands]

Borrowings under long-term debt [USD, thousands]

Repayments of long-term debt [USD, thousands]

Payments of debt issuance costs [USD, thousands]

Principal payments on finance lease obligations [USD, thousands]

Proceeds from issuance of common shares and exercise of warrants, net of issuance costs [USD, thousands]

Net cash provided by (used in) financing activities [USD, thousands]

Net effect of exchange rate fluctuations on cash and cash equivalents [USD, thousands]

Net change in cash and cash equivalents [USD, thousands]

Cash and cash equivalents, Beginning of period [USD, thousands]

Cash and cash equivalents, End of period [USD, thousands]

39ef3e7c0b045471c8706a06ae5433ad9b6a6a2c70f1e8cc5e20bd3d75f04730

ACUREN (TIC)

Financials